NL-OMON25918已完成不适用
De-implementation strategy to reduce overtreatment of asymptomatic bacteriuria: the ROAB-study
Amsterdam UMC, location AMC0 个研究点目标入组 420 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 420
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Our target size is at least 420 patients.
- •Patients =18 years old who had urine tests (culture and/or urinalysis), that were obtained during presentation at the emergency department will be screened for eligibility.
排除标准
- •-Negative urinalysis and negative urine cultures
- •-Patients with symptomatic UTI
- •-Patients with an alternate site of infection for which they receive antimicrobial treatment
- •-Patients with ASB and risk factors, defined as pregnant women, patients prior to planned invasive urologic procedures associated with mucosal trauma (including transurethral surgery of the prostate or bladder, ureteroscopy including lithotripsy, and percutaneous stone surgery), and high-risk neutropenia (defined as absolute neutrophil count <500 cells/µl).
研究者
相似试验
已完成
不适用
ifestyle intervention for metabolic syndromeObesityHypertensionACTRN12616000235404orthern Health90
尚未招募
Unknown
Evaluation of medication withdrawal in reducing the falls and fall risk in elderly Population on fall risk-increasing drugsCTRI/2023/12/060516Indian Council of Medical Research
已完成
不适用
An intervention aimed at the prevention of excessive weight gain during pregnancyWeight-gain during pregnancyPregnancy and ChildbirthWeight-gainISRCTN85313483etherlands Organisation for Health Research and Development (ZonMw)300
招募中
不适用
Development of novel treatment strategy to prevent progression of arteriosclerosis in dialysis patientsend stage renal diseaseJPRN-UMIN000020384second department of internal medicine, Kansai Medical University Hirakata hospital100
已完成
2 期
De-escalation and stopping treatment of imatinib, nilotinib or sprycel in chronic myeloid leukaemiaTopic: National Cancer Research NetworkSubtopic: Haematological OncologyDisease: Leukaemia (chronic)Chronic myelogenous leukaemiaCancerISRCTN74084226niversity of Liverpool (UK)168